Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer

NCT00320515 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm, Gastric

Interventions

DRUG: pemetrexed
DRUG: cisplatin

Sponsor

Eli Lilly and Company